Platelets' glycoproteins and their ligands in patients with intermittent claudication

• Published in: International angiology Vol. 22; no. 2; pp. 164 - 171
• Main Authors: GOSK-BIERSKA, I, ADAMIEC, R, SZUBA, A
• Format: Journal Article
• Language: English
• Published: Torino Minerva Medica 01.06.2003; Edizioni Minerva Medica
• Subjects: Adult; Aged; Biological and medical sciences; Biomarkers - blood; Blood and lymphatic vessels; Cardiology. Vascular system; Coronary Disease - blood; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Female; Fibrinogen - metabolism; Humans; Intermittent Claudication - blood; Ligands; Male; Medical sciences; Middle Aged; Platelet Membrane Glycoproteins - metabolism; Smoking - blood; Statistics as Topic; Triglycerides - blood; Uric Acid - blood; von Willebrand Factor - metabolism; Human; Claudication; Platelet activation; Pathogenesis; Tobacco smoking; Peripheral vascular disease; Cardiovascular disease; Monoclonal antibody; Platelet glycoprotein; Glycoprotein Ib; Platelet glycoprotein GP Ib IX complex; Arterial disease; Vascular disease; Arteriopathy; Platelet; Intermittent; von Willebrand factor; Atherosclerosis; Fibrinogen; GPII b/IIIa, complex
• ISSN: 0392-9590; 1827-1839

Platelet thrombi play critical role in pathogenesis of cardiovascular complications in atherosclerotic peripheral arterial disease (PAOD). The aim of this study was to evaluate the concentration of platelets GP IIb/IIIa, GP I b/IX and plasma levels of their ligands (fibrinogen and vWF) and their relation to other atherosclerotic risk factors in the patients with intermittent claudication secondary to PAOD. Consecutive patients of the University Vascular Clinic were studied: 64 claudicants and 38 controls were enrolled. The concentration of platelets GPII b/IIIa and GP Ib/IX was estimated by ELISA method using monoclonal antibody against GPII b/IIIa (CD41a) and GPI b/IX (CD42a Immunotech). Plasma levels of vWF, fibrinogen, and platelets were measured by routine Plasma vWF (145+/-41%), fibrinogen (3.8+/-1 g/l) and platelet concentration of GP Ib/IX (121.1+/-23.39), GPIIb/IIIa (117.9 6 +/-32.7%), as well as plasma lipids and uric acid were statistically higher in claudicants than in controls (vWF: 103+/-42%, fibrinogen: 2.9+/-0.5 g/l, GP Ib/IX: 100+/-16.9%, GP IIb/IIIa: 100+/-29.4%). We have observed statistically higher concentration of GP IIb/IIIa and GP Ib/IX in smoking patients than in non-smoking patients with PAOD and significant correlation between the concentration of GP Ib/IX and GP IIb/IIIa and plasma fibrinogen in patients with PAOD and controls. Our results demonstrate higher platelet concentration of GP Ib/IX,GP IIb/IIIa and elevated plasma levels of ligands for platelets receptors-fibrinogen and vWF in patients with PAOD. This prothrombotic conditions may explain increased cardiovascular morbidity and mortality in this patient's group.